NEW YORK (GenomeWeb) – Thermo Fisher Scientific said today that it has licensed its procalcitonin biomarker assay, BRAHMS PCT, to Siemens Healthineers.
Siemens' Atellica BRAHMS PCT assay received clearance from the US Food and Drug Administration on July 16, which the company announced in August.